As of March 27th (Friday), GAIA-BT is starting a new paradigm in biology research - one agent at a time.

From nutraceuticals (GAIA-Elix) to oncology drugs (GAIA-Onco) and radiopharmaceuticals (GAIA-Onco+), our specialized AI Agents support researchers and executives in decision-making. Powered by our bio-specialized, multi-stage AI pipeline and collaborative Human-in-the-Loop workflow, you can now generate even more accurate strategic reports in minutes.

Sign up and get your answers today!